News | Population Health | April 04, 2024

Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA).

Early coronary disease and impaired heart function, with increased coronary vessel wall thickness, in asymptomatic, middle-aged individuals living with HIV has been reported in a new study published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA). Image courtesy: RSNA


April 4, 2024 — A new study found increased coronary vessel wall thickness that was significantly associated with impaired diastolic function in asymptomatic, middle-aged individuals living with HIV. The study, “Association of Coronary Wall Thickening and Diminished Diastolic Function in Asymptomatic, Low Cardiovascular Disease-Risk Persons Living with HIV” was published today in Radiology: Cardiothoracic Imaging, a journal of the Radiological Society of North America (RSNA), which issued a news summary on the study, detailed below.

As effective therapy drugs increase the life expectancy for people living with HIV, non-AIDS-related health concerns are increasingly common. Recent research has shown that cardiovascular disease is higher in persons living with HIV compared with individuals without HIV, with an estimated 4-fold higher rate of sudden cardiac death compared with the general population.

Approximately 39 million people were living with HIV at the end of 2022, according to the World Health Organization (WHO). Since 2010, HIV-related deaths have been reduced by 51%, but HIV continues to be a major global public health issue, claiming 40.4 million lives so far.

Study Details

Researchers at the National Institutes of Health (NIH) set out to assess early coronary atherosclerosis burden, and its relation to how the heart is functioning, in people living with HIV who were asymptomatic and had low cardiovascular disease risk. For the study, the researchers recruited 74 adults (mean age of 49 years) living with HIV without known cardiovascular disease and 25 matched healthy controls (mean age of 46 years). Controls were negative for HIV and were required to be healthy with no known significant medical conditions, including coronary disease. All underwent MRI to measure coronary vessel wall thickness and an echocardiogram to assess left ventricular function.

“Prior studies have shown cardiovascular disease in persons living with HIV, however not at such an early stage,” said senior author Ahmed M. Gharib, M.D., senior clinical investigator, and director of the Biomedical and Metabolic Imaging Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in Bethesda, Maryland. 

The HIV and control groups were matched by corresponding age, sex and race. A detailed medical history, physical examination and laboratory tests were obtained from participants, including detailed review of any exposure to antiretroviral therapy — the combination of several antiretroviral medicines used to slow the rate at which HIV makes copies of itself (multiplies) in the body — and traditional cardiovascular disease risk factors. Each participant had lab tests that included the following: fasting lipid panel, T-cell counts and HIV viral load.

The results showed increased coronary vessel wall thickness in the HIV group, compared to controls. The increased coronary artery vessel wall thickness was independently associated with elevated left ventricular mass index and impaired diastolic function.

Coronary artery vessel wall thickness was also associated with the duration of exposure to didanosine, one of the medications used in combination with other drugs for the treatment of HIV.

“The ability to detect early coronary artery disease in persons living with HIV and potentially prevent detrimental effects on the heart muscle is important,” said lead author Khaled Z. Abd-Elmoniem, Ph.D., M.H.S., staff scientist in NIDDK’s Biomedical and Metabolic Imaging Branch. He added, “This research shows the impact of HIV on developing subtle subclinical coronary artery disease and its effects on heart function.”

The researchers emphasized that early identification of subclinical cardiovascular disease in young HIV patients is an urgent necessity, potentially opening avenues for more effective intervention and disease management.

Collaborating with Drs. Gharib and Abd-Elmoniem were Hadjira Ishaq, M.D., Julia Purdy, M.S.N., Jatin Matta, P.A.-C., Ahmed Hamimi, M.D., Hwaida Hannoush, M.D., and Colleen Hadigan M.D.

More information: www.rsna.org

Reference:

https://pubs.rsna.org/doi/10.1148/ryct.230102 


Related Content

News | Artificial Intelligence

May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths ...

Time May 15, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Breast Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

Digital radiography (DR) continues to advance at a rapid pace with today’s technological innovations and evolving ...

Time May 06, 2024
arrow
News | Pediatric Imaging

May 2, 2024 — Head and abdominal trauma is a leading cause of death for children. About 1%–2% of children who come to ...

Time May 02, 2024
arrow
Feature | Radiology Business

Beginning this spring, ITN will begin sending out a bi-monthly survey to our readers on a variety of topics, which we ...

Time May 02, 2024
arrow
News | Breast Imaging

April 30, 2024 — Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports ...

Time April 30, 2024
arrow
Subscribe Now